NCT06786000

Brief Summary

This clinical trial aims to evaluate the effect of different types of tDCS modulation with mCIMT in improving affected upper-limb motor function for stroke patients. The main question it seeks to answer: Which type of tDCS (bi-hemispheric, anodal, or cathodal) combined with the mCIMT program leads to greater improvement in affected upper-limb function in patients with stroke? Researchers will compare these three types of tDCS to a sham tDCS. To see which kind of tDCS protocol combined with the mCIMT program will be more effective in improving affected upper-limb function for stroke patients. Participants will:

  1. 1.Participants will receive 12 sessions of mCIMT combined with tDCS or mCIMT alone.
  2. 2.Visit the clinic three times a week for four weeks.
  3. 3.Participants will do fMRI and TMS before and after the program and three times of assessment before and after two weeks after the program.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for not_applicable stroke

Timeline
Completed

Started Apr 2023

Typical duration for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 11, 2023

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

January 2, 2025

Completed
20 days until next milestone

First Posted

Study publicly available on registry

January 22, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 11, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 11, 2025

Completed
Last Updated

January 22, 2025

Status Verified

January 1, 2025

Enrollment Period

2 years

First QC Date

January 2, 2025

Last Update Submit

January 14, 2025

Conditions

Keywords

strokeischemic strokehemorrhagic stroketDCSmCIMThemiparesisneural activationprimary motor cortexNIBSnon invasive brain stimulationtrans direct current stimulationmodified constraint induced movement therapy

Outcome Measures

Primary Outcomes (6)

  • Fugl-Meyer Assessment Scale - upper extremity (FMA-UE)

    The upper extremity domain of FMA consists of 33 items (reflex activity, volitional movement within synergies, volitional movement mixing synergies, volitional movement with little or no synergy, wrist, hand, coordination/ speed). On a 3-point ordinal scale, 0 = cannot perform, 1 = performs partially, and 2 = performs fully. The upper extremity domain has a total score of 66. A higher score indicated better performance of the affected side.

    at baseline, and after 2 weeks, and after intervention (4 weeks).

  • Wolf Motor Function Test (WMFT)

    It is used to assess upper-limb performance through timed and functional tasks (Wolf et al., 2001). The WMFT is preferred to frequently used upper limb performance tests since it assesses a wide range of functional activities (from simple to complex) and investigates both performance time and movement quality (Morris et al., 2001). The modified WMFT consists of 17 items, 2 of which are strength measurements, and the remaining 15 items are functional tasks that gradually progress from simple movements in the proximal joint to complex movements in the distal joint. Each of the 15 tasks is timed to completion, up to a maximum of 120 seconds (Wolf et al., 2001). The items are scored on a 6-point scale ranging from 0 (does not attempt with the upper limb being tested) to 5 (uses the limb being tested, movement appears normal) (Wolf et al., 2005). A lower score indicates a lower functional level (Wolf et al., 2005).

    at baseline, and after 2 weeks, and after intervention ( 4 weeks).

  • Nine-Hole Peg Test (NHPT)

    The Nine-Hole Peg Test (NHPT) is one of the most commonly used performance tests for measuring hand function and manual dexterity in stroke patients (Chen et al., 2009; Mathiowetz et al., 1985). The NHPT consists of a container with nine pegs and a pegboard with nine holes. The board will be placed at the midline of the patient, with the container containing the pegs on the side of the hand being evaluated. The NHPT requires the patient to pick up the pegs from the container with the affected upper limb, transfer and insert them into the holes of the pegboard until it is full, and then return them to the container. Patients will be instructed to complete the test as quickly and accurately as possible (Sommerfeld et al., 2004). The score will be based on the time it takes to complete the test activity, which will be recorded in seconds. The stopwatch should be started when the patient touches the first peg until the last peg is put in the container (Oxford Grice et al., 2003).

    at baseline, and after 2 weeks, and after intervention ( 4 weeks).

  • Cortical Excitability Assessment

    The Transcranial Magnetic Stimulation (TMS) will be used to assess the corticospinal excitability through the measurement of the TMS-elicited motor evoked potential (MEP) in both the lesioned and the nonlesioned motor cortices (Wassermann et al., 2008). Online monitoring of the electromyographic (EMG) activity in response to TMS will be performed, MEPs will be recorded from the left and the right first interosseous (FDI) muscles

    at baseline and after intervention ( 4 weeks).

  • Functional magnetic resonance imaging (fMRI)

    Functional magnetic resonance imaging (fMRI) is a type of magnetic resonance imaging (MRI) that measures brain activity and connectivity. During an fMRI scan, a block design will be used. Each scan will take 6 minutes and be split into six blocks in the following order, with a rest of 30 seconds between each of the 15 contractions that last 2 seconds each and 30 seconds of rest in between (Wen et al., 2014). In each task, participants will be asked to grip a rubber ball at a target pressure of 30% of their maximum voluntary contraction using their affected hand (Cheng et al., 2021; Ismail et al., 2014). Visual feedback will be provided for the patients to guide the movement (Könönen et al., 2012).

    at baseline and after intervention ( 4 weeks).

  • Wolf Motor Function Test (WMFT)

    It is used to assess upper-limb performance through timed and functional tasks (Wolf et al., 2001). The WMFT is preferred to frequently used upper limb performance tests since it assesses a wide range of functional activities (from simple to complex) and investigates both performance time and movement quality (Morris et al., 2001). The modified WMFT consists of 17 items, 2 of which are strength measurements, and the remaining 15 items are functional tasks that gradually progress from simple movements in the proximal joint to complex movements in the distal joint. Each of the 15 tasks is timed to completion, up to a maximum of 120 seconds (Wolf et al., 2001). The items are scored on a 6-point scale ranging from 0 (does not attempt with the upper limb being tested) to 5 (uses the limb being tested, movement appears normal) (Wolf et al., 2005). A lower score indicates a lower functional level (Wolf et al., 2005).

    at baseline and after intervention ( 4 weeks).

Secondary Outcomes (2)

  • Arabic version of Stroke Impact Scale (SIS-16)

    at baseline, and after 2 weeks, and after intervention ( 4 weeks).

  • Motor Activity log (MAL)

    at baseline, week 1, week 2, week 3 and after intervention ( 4 weeks).

Study Arms (4)

Anodal tDCS combined with mCIMT

EXPERIMENTAL

20 minutes of anodal tDCS followed by 1 hour of the mCIMT program

Device: Anodal tDCS combined with mCIMT

Cathodal tDCS combined with mCIMT

EXPERIMENTAL

20 minutes of cathodal tDCS followed by 1 hour of the mCIMT program

Device: Cathodal tDCS combined with mCIMT

Bihemispheric tDCS combined with mCIMT

EXPERIMENTAL

20 minutes of bihemispheric tDCS followed by 1 hour of the mCIMT program

Device: Bihemispheric tDCS combined with mCIMT

Sham tDCS combined with mCIMT

SHAM COMPARATOR

20 minutes of anodal tDCS (after 30 seconds of stimulation, the stimulator will switch off) followed by 1 hour of the mCIMT program

Device: Sham tDCS combined with mCIMT

Interventions

20 minutes of anodal tDCS followed by 1 hour of the mCIMT program. The anodal electrode will be placed over the ipsilesional M1 (primary motor cortex, C3 or C4 according to EEG 10/20 system), and the cathodal electrode over the contralateral supraorbital area (Fp1 or Fp2) ). Leading to subthreshold depolarization to promote cortical excitation. And twelve different oriented tasks will be used during the 1-hour training period.

Anodal tDCS combined with mCIMT

20 minutes of cathodal tDCS followed by 1 hour of the mCIMT program. the cathodal electrode will be placed over the contralesional M1, and the anodal electrode over the contralateral supraorbital area (Fp1 or Fp2). leading to subthreshold polarization to promote cortical inhibition. And twelve different oriented tasks will be used during the 1-hour training period.

Cathodal tDCS combined with mCIMT

20 minutes of Bihemispheric tDCS followed by 1 hour of the mCIMT program. the cathodal electrode will be placed over the primary motor cortex (M1) of the contralesional hemisphere and the anodal electrode will be placed above the ipsilateral M1 position (C3 or C4 positions, according to the 10/20 EEG system). And twelve different oriented tasks will be used during the 1-hour training period.

Bihemispheric tDCS combined with mCIMT

20 minutes of sham tDCS followed by 1 hour of the mCIMT program. the same stimulation place and parameters will be used as in the anodal group. However, after 30 seconds of stimulation, the stimulator will switch off. This provides the participants with the experience of the initial itchy sensation that occurs during tDCS, which is required for efficient masking. And twelve different oriented tasks will be used during the 1-hour training period.

Sham tDCS combined with mCIMT

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult participants clinically diagnosed and confirmed by imaging of ischemic or hemorrhagic cerebrovascular accident (Dahl et al., 2008; Jin et al., 2019).
  • Participant's age older than 18 years (Baltar et al., 2020).
  • Stroke onset more than 3 months with unilateral motor deficits (Lin et al., 2010).
  • Adequate cognitive function is required to follow instructions. The Arabic version of the Mini Mental State Examination (MMSE) should be ≥24 (Kim, 2021).
  • ° of active extension to the metacarpophalangeal and interphalangeal joints and 20° at wrist will be assessed by manual goniometer (Dahl et al., 2008).
  • Fugl-Meyer assessment (FMA) scores between 19 and 58, indicating moderate to mild impairments.
  • Not participating in other clinical, or research studies at the same time.

You may not qualify if:

  • Severe muscle spasticity at the affected limb at all joints (the Modified Ashworth Scale scores \> 3) (Baltar et al., 2020).
  • Contraindications to NIBS (Bornheim et al., 2019).
  • Unilateral neglect (Dahl et al., 2008)
  • Other neurologic or orthopedic conditions that may affect hand function.
  • Unstable medical conditions.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

King Saud University Medical City

Riyadh, Riyadh Region, 12372, Saudi Arabia

RECRUITING

Related Publications (1)

  • Baltar A, Piscitelli D, Marques D, Shirahige L, Monte-Silva K. Baseline Motor Impairment Predicts Transcranial Direct Current Stimulation Combined with Physical Therapy-Induced Improvement in Individuals with Chronic Stroke. Neural Plast. 2020 Nov 25;2020:8859394. doi: 10.1155/2020/8859394. eCollection 2020.

    PMID: 33299400BACKGROUND

MeSH Terms

Conditions

StrokeIschemic StrokeHemorrhagic StrokeParesis

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Alaa M. Albishi, PhD in Rehabilitation Sciences

CONTACT

Ahmad O. Alokaily, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

January 2, 2025

First Posted

January 22, 2025

Study Start

April 11, 2023

Primary Completion

April 11, 2025

Study Completion

April 11, 2025

Last Updated

January 22, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations